Bruker (BRKR) Other Non-Current Assets (2010 - 2026)
Bruker's (BRKR) quarterly Other Non-Current Assets came in at $816.2 million in Q2 2026, up 2.05% on a YoY basis from $799.8 million in Q2 2025, and down 1.92% quarter-over-quarter from $832.2 million in Q1 2026.
Analysis
Bruker (BRKR) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Other Non-Current Assets for 17 consecutive years, with $816.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets rose 2.05% year-over-year to $816.2 million; the trailing twelve-month figure through Jun 2026 stood at $816.2 million (up 2.05% YoY), and the FY2025 full-year result was $836.8 million, up 259.6% from the prior year.
- Other Non-Current Assets slipped to $816.2 million in Q2 2026 per BRKR's latest filing, from $832.2 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $868.8 million in Q3 2025 and bottomed at $155.1 million in Q4 2022.
- Historically, Other Non-Current Assets has averaged $437.7 million across 5 years, with a median of $288.5 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slumped 41.96% in 2024, then surged 331.16% in 2025.
- Over 5 years, Other Non-Current Assets stood at $155.1 million in 2022, then gained by 18.63% to $184.0 million in 2023, then climbed by 26.47% to $232.7 million in 2024, then soared by 259.6% to $836.8 million in 2025, then decreased by 2.46% to $816.2 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $816.2 million, $832.2 million, and $836.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 1.07 Bn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 576.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 309.11 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 264.34 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 101.70 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 4.05 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 15.31 Mn |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | 816.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 816.20 Mn |
| Mar 31, 2026 | 832.20 Mn |
| Dec 31, 2025 | 836.80 Mn |
| Sep 30, 2025 | 868.80 Mn |
| Jun 30, 2025 | 799.80 Mn |
| Mar 31, 2025 | 698.00 Mn |
| Dec 31, 2024 | 232.70 Mn |
| Sep 30, 2024 | 238.10 Mn |
| Jun 30, 2024 | 185.50 Mn |
| Mar 31, 2024 | 193.60 Mn |
| Dec 31, 2023 | 184.00 Mn |
| Sep 30, 2023 | 410.20 Mn |
| Jun 30, 2023 | 292.70 Mn |
| Mar 31, 2023 | 294.20 Mn |
| Dec 31, 2022 | 155.10 Mn |
| Sep 30, 2022 | 283.30 Mn |
| Jun 30, 2022 | 272.60 Mn |
| Mar 31, 2022 | 284.30 Mn |
| Dec 31, 2021 | 70.80 Mn |
| Sep 30, 2021 | 206.70 Mn |